PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.89%
Negative revenue growth while 1097.HK stands at 10.68%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-14.07%
Negative gross profit growth while 1097.HK is at 6.03%. Joel Greenblatt would examine cost competitiveness or demand decline.
-83.31%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-81.90%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-80.77%
Negative net income growth while 1097.HK stands at 54.07%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.07%
Share reduction more than 1.5x 1097.HK's 0.79%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.07%
Diluted share reduction more than 1.5x 1097.HK's 0.79%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
81.69%
Dividend growth at 50-75% of 1097.HK's 131.43%. Martin Whitman would question if the firm lags in returning cash to shareholders.
-50.82%
Negative OCF growth while 1097.HK is at 7.93%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-226.06%
Negative FCF growth while 1097.HK is at 19.38%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
2.01%
5Y revenue/share CAGR under 50% of 1097.HK's 76.33%. Michael Burry would suspect a significant competitive gap or product weakness.
-7.62%
Negative 3Y CAGR while 1097.HK stands at 153.94%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-17.87%
Negative 5Y OCF/share CAGR while 1097.HK is at 94.80%. Joel Greenblatt would question the firm’s operational model or cost structure.
136.10%
Positive 3Y OCF/share CAGR while 1097.HK is negative. John Neff might see a big short-term edge in operational efficiency.
No Data
No Data available this quarter, please select a different quarter.
108.82%
5Y net income/share CAGR at 50-75% of 1097.HK's 187.75%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-26.24%
Negative 3Y CAGR while 1097.HK is 344.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
60.13%
Dividend/share CAGR of 60.13% while 1097.HK is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-15.38%
We cut SG&A while 1097.HK invests at 8.64%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.